The advertisement promotes Komzifti (ziftomenib) for treating adult patients with R/R NPM1-m AML, highlighting the prevalence of NPM1 mutations and providing important safety information regarding differentiation syndrome.
Creative Information
| CID: | 776ef52d-f299-4d85-a8f7-99b0092f015b |
| CRID: | 25_s584dtdu |
| Domain: | imuldosa.com |
| Seat: | TTD |
| Size: | 300x250 |
| Bid: | $3.08 |
| Timestamp: | 2/2/2026, 2:51:54 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 2/2/2026, 2:52:17 AM | 4.41s | |
| adomain_analysis | success | 2/2/2026, 2:52:35 AM | 2.81s | |
| adomain_capture | success | 2/2/2026, 2:52:32 AM | 17.96s | |
| ad_render | success | 2/2/2026, 2:52:13 AM | 17.22s | |
| brand_mapping | success | 2/2/2026, 2:52:34 AM | 2.26s | |
Analysis Results
Ad Format: banner
Brands:
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 797.70 KB | ||||||||||||||||||||||
| Render Time: | 8.34 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 816.87 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

